Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2003 | 09-2003 | 06-2003 | 03-2003 | 12-2002 | |
| Sales | 59,025 | 47,058 | 42,736 | 36,780 | 35,261 |
| Cost of Goods | 20,934 | 18,870 | 17,090 | 13,703 | 14,168 |
| Gross Profit | 38,091 | 28,188 | 25,646 | 23,077 | 21,093 |
| Operating Expenses | 26,029 | 18,136 | 17,447 | 16,340 | 14,481 |
| Operating Income | 12,996 | 10,922 | 8,289 | 7,440 | 6,780 |
| Interest Expense | 771 | 922 | 1,024 | 7 | 23 |
| Other Income | 2,814 | 1,043 | 1,277 | 1,132 | 732 |
| Pre-tax Income | 15,039 | 11,043 | 8,542 | 8,565 | 7,489 |
| Income Tax | 5,867 | 4,210 | 3,124 | 3,127 | -17,885 |
| Net Income Continuous | 9,172 | 6,833 | 5,418 | 5,438 | 25,374 |
| Net Income | $9,172 | $6,833 | $5,418 | $5,438 | $25,374 |
| EPS Basic Total Ops | 0.16 | 0.12 | 0.10 | 0.09 | 0.44 |
| EPS Basic Continuous Ops | 0.16 | 0.12 | 0.10 | 0.09 | 0.44 |
| EPS Diluted Total Ops | 0.14 | 0.12 | 0.09 | 0.09 | 0.41 |
| EPS Diluted Continuous Ops | 0.11 | 0.11 | 0.09 | 0.09 | 0.41 |
| EBITDA(a) | $15,763 | $13,219 | $10,355 | $9,353 | $8,757 |